• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于卵巢癌纵向CA125的联合模型来预测复发。

A joint model based on longitudinal CA125 in ovarian cancer to predict recurrence.

作者信息

Chang Chung, Chiang An Jen, Chen Wei-An, Chang Hsueh-Wen, Chen Jiabin

机构信息

Department of Applied Mathematics, National Sun Yat-sen University, Kaohsiung, Taiwan, Republic of China.

Department of Obstetrics & Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of China.

出版信息

Biomark Med. 2016;10(1):53-61. doi: 10.2217/bmm.15.110. Epub 2015 Nov 13.

DOI:10.2217/bmm.15.110
PMID:26565119
Abstract

AIMS

To develop a new package of joint model to fit longitudinal CA125 in epithelial ovarian cancer relapse.

PATIENTS & METHODS: Included were 305 epithelial ovarian cancer patients who reached complete remission after cytoreductive surgery and first-line chemotherapy. Univariate and multivariate analysis with a joint model was performed to select independent risk factors, which were subsequently combined to predict recurrence.

RESULTS

Independent factors were longitudinal CA125, age, stage and residual tumor size (p < 0.05). Prediction of recurrence with these factors had an average of 80.7% accuracy, 5.6-10.7% better than kinetic factors.

CONCLUSION

The new package of joint model fits longitudinal CA125 well. Potential application can be extended to other biomarkers.

摘要

目的

开发一种新的联合模型包,以拟合上皮性卵巢癌复发时的纵向CA125数据。

患者与方法

纳入305例上皮性卵巢癌患者,这些患者在肿瘤细胞减灭术和一线化疗后达到完全缓解。采用联合模型进行单因素和多因素分析以选择独立危险因素,随后将这些因素结合起来预测复发情况。

结果

独立因素为纵向CA125、年龄、分期和残余肿瘤大小(p<0.05)。利用这些因素预测复发的准确率平均为80.7%,比动力学因素高5.6 - 10.7%。

结论

新的联合模型包能很好地拟合纵向CA125数据。其潜在应用可扩展到其他生物标志物。

相似文献

1
A joint model based on longitudinal CA125 in ovarian cancer to predict recurrence.一种基于卵巢癌纵向CA125的联合模型来预测复发。
Biomark Med. 2016;10(1):53-61. doi: 10.2217/bmm.15.110. Epub 2015 Nov 13.
2
The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study.人附睾蛋白4在预测上皮性卵巢癌患者复发中的作用——来自OVCAD研究的结果。
Tumour Biol. 2016 Mar;37(3):3009-16. doi: 10.1007/s13277-015-4031-9. Epub 2015 Sep 29.
3
Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study.血清CA125对上皮性卵巢癌术后患者的随访监测有临床价值吗?一项12年研究的结果。
J Ovarian Res. 2017 Mar 11;10(1):14. doi: 10.1186/s13048-017-0310-y.
4
Does Human Epididymis Protein 4 (HE4) Have a Role in Prediction of Recurrent Epithelial Ovarian Cancer.人附睾蛋白4(HE4)在复发性上皮性卵巢癌的预测中起作用吗?
Asian Pac J Cancer Prev. 2016;17(9):4483-4486.
5
[Expression of serum human epididymis protein 4 in epithelial ovarian cancer and its correlation with prognosis].[血清人附睾蛋白4在上皮性卵巢癌中的表达及其与预后的相关性]
Zhonghua Zhong Liu Za Zhi. 2013 Jun;35(6):445-9.
6
Ovarian fibroma/fibrothecoma with elevated serum CA125 level: A cohort of 66 cases.血清CA125水平升高的卵巢纤维瘤/纤维卵泡膜细胞瘤:66例队列研究
Medicine (Baltimore). 2018 Aug;97(34):e11926. doi: 10.1097/MD.0000000000011926.
7
Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer.血管内皮生长因子表达与血清CA125相关,是预测上皮性卵巢癌铂类化疗耐药及腹水形成的有用工具。
Oncotarget. 2015 Sep 29;6(29):28491-501. doi: 10.18632/oncotarget.4427.
8
Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.在复发的上皮性卵巢癌患者中,F-18氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(F-18 FDG PET/CT)所测量的定量代谢参数可预测复发后的生存情况。
Gynecol Oncol. 2015 Mar;136(3):498-504. doi: 10.1016/j.ygyno.2014.12.032. Epub 2014 Dec 31.
9
[Potential value of CA125 kinetic monitoring in the initial management of advanced epithelial ovarian cancer].CA125动态监测在晚期上皮性卵巢癌初始治疗中的潜在价值
Ann Biol Clin (Paris). 2011 Sep-Oct;69(5):597-604. doi: 10.1684/abc.2011.0620.
10
A Biomarker Panel Increases the Diagnostic Performance for Epithelial Ovarian Cancer Type I and II in Young Women.一种生物标志物组合可提高年轻女性中I型和II型上皮性卵巢癌的诊断效能。
Anticancer Res. 2016 Mar;36(3):957-65.

引用本文的文献

1
A Joint Model Based on Post-Treatment Longitudinal Prognostic Nutritional Index to Predict Survival in Nasopharyngeal Carcinoma.基于治疗后纵向预后营养指数的联合模型预测鼻咽癌生存率
Cancers (Basel). 2024 Mar 3;16(5):1037. doi: 10.3390/cancers16051037.
2
Dynamic Prediction of Resectability for Patients with Advanced Ovarian Cancer Undergoing Neo-Adjuvant Chemotherapy: Application of Joint Model for Longitudinal CA-125 Levels.接受新辅助化疗的晚期卵巢癌患者可切除性的动态预测:CA-125水平纵向联合模型的应用
Cancers (Basel). 2022 Dec 30;15(1):231. doi: 10.3390/cancers15010231.
3
Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma.
建立和验证预测上皮性卵巢癌 3 年复发风险的列线图。
BMC Cancer. 2020 Sep 29;20(1):938. doi: 10.1186/s12885-020-07402-2.
4
Value of [18F]FDG-PET/CT and CA125, serum levels and kinetic parameters, in early detection of ovarian cancer recurrence: Influence of histological subtypes and tumor stages.[18F]氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描([18F]FDG-PET/CT)以及CA125血清水平和动力学参数在卵巢癌复发早期检测中的价值:组织学亚型和肿瘤分期的影响
Medicine (Baltimore). 2018 Apr;97(17):e0098. doi: 10.1097/MD.0000000000010098.